HomeCompareWHTCF vs PLD

WHTCF vs PLD: Dividend Comparison 2026

WHTCF yields 73.41% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $4.68M in total portfolio value· pulled ahead in Year 9
10 years
WHTCF
WHTCF
● Live price
73.41%
Share price
$2.72
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.23M
Annual income
$334,556.35
Full WHTCF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — WHTCF vs PLD

📍 PLD pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWHTCFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WHTCF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WHTCF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WHTCF
Annual income on $10K today (after 15% tax)
$6,239.68/yr
After 10yr DRIP, annual income (after tax)
$284,372.90/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,753,743.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WHTCF + PLD for your $10,000?

WHTCF: 50%PLD: 50%
100% PLD50/50100% WHTCF
Portfolio after 10yr
$3.57M
Annual income
$2,542,640.77/yr
Blended yield
71.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

WHTCF
Analyst Ratings
2
Buy
1
Hold
Consensus: Buy
Altman Z
1.3
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WHTCF buys
0
PLD buys
0
No recent congressional trades found for WHTCF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWHTCFPLD
Forward yield73.41%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$1.23M$5.91M
Annual income after 10y$334,556.35$4,750,725.19
Total dividends collected$1.06M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: WHTCF vs PLD ($10,000, DRIP)

YearWHTCF PortfolioWHTCF Income/yrPLD PortfolioPLD Income/yrGap
1$18,041$7,340.80$11,241$540.96+$6.8KWHTCF
2$31,681$12,376.99$13,019$991.13+$18.7KWHTCF
3$54,211$20,312.79$15,801$1,870.97+$38.4KWHTCF
4$90,491$32,484.78$20,609$3,701.21+$69.9KWHTCF
5$147,502$50,677.10$29,919$7,867.97+$117.6KWHTCF
6$235,028$77,200.91$50,631$18,617.74+$184.4KWHTCF
7$366,444$114,963.60$105,528$51,352.20+$260.9KWHTCF
8$559,614$167,518.98$287,364$174,449.42+$272.3KWHTCF
9← crossover$837,877$239,089.96$1,081,760$774,280.77$243.9KPLD
10$1,231,084$334,556.35$5,908,209$4,750,725.19$4.68MPLD

WHTCF vs PLD: Complete Analysis 2026

WHTCFStock

WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers end-to-end omni-channel patient services, including primary care; physiotherapy, occupational therapy, chiropractic, dietary, mental health counselling, and sleep related services; specialized care, including gastroenterologists; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services. The company also operates OSCAR Pro, an electronic medical records platform; telehealth platforms, including Tia Health, VirtualClinic+, VirtuelMed, Adracare, and Circle Medical; Apps.health, a digital health app marketplace; Insig, which offers virtual care and digital patient engagement services; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions. As of December 31, 2021, the company operated 30 primary care and executive care clinics; and provides primary care, specialty care, and accredited diagnostic health services through 49 locations across Ontario. The company was formerly known as Wellness Lifestyles Inc. and changed its name to WELL Health Technologies Corp. in July 2018. WELL Health Technologies Corp. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Full WHTCF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this WHTCF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WHTCF vs SCHDWHTCF vs JEPIWHTCF vs OWHTCF vs KOWHTCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.